BACKGROUND: Survivors of Hodgkin lymphoma (HL) have significant cardiovascular risk and require long-term surveillance. The current study assessed the prevalence of coronary artery disease (CAD) by coronary computed tomography angiography (CCTA) in adult survivors of childhood HL. METHODS: Thirty-one survivors of HL, 13 of whom (42%) were treated with radiotherapy (RT) only and 18 of whom (58%) were treated with multimodal therapy, underwent CCTA, echocardiography, electrocardiography (ECG), and treadmill stress testing. Obstructive CAD was defined as ≥50% occlusion of the left main or ≥70% occlusion of the left anterior descending, left circumflex, or right coronary arteries on CCTA. Echocardiograms with resting wall motion abnormalities or an ejection fraction <50%; ECGs with Q waves, ST abnormalities without Q waves, or T-wave abnormalities without Q waves; and a J-point depression of ≥1 mm with a horizontal or downsloping ST segment on stress testing were considered abnormal. RESULTS: The prevalence of disease in participants (median age, 40 years [range, 26 years-55 years]; median time from cancer diagnosis, 24 years [range, 17 years-39 years]) was 39%, with 39 plaques detected among 12 survivors. Three participants (10%) treated with RT only had 4 obstructive lesions; 9 patients (29%; 5 of whom were treated with RT only and 4 of whom were treated with multimodal therapy) had nonobstructive lesions. Approximately 15% of lesions involved the left main, 21% involved the proximal left anterior descending, 18% involved the proximal right coronary, and 13% involved the proximal left circumflex arteries. Of the 12 participants found to have CAD by CCTA, 7 had a positive ECG, 1 had a positive echocardiogram, and 1 had a positive stress test. CONCLUSIONS: CCTA identified CAD in a substantial percentage of survivors of HL and may be an effective screening modality for this population.
BACKGROUND: Survivors of Hodgkin lymphoma (HL) have significant cardiovascular risk and require long-term surveillance. The current study assessed the prevalence of coronary artery disease (CAD) by coronary computed tomography angiography (CCTA) in adult survivors of childhood HL. METHODS: Thirty-one survivors of HL, 13 of whom (42%) were treated with radiotherapy (RT) only and 18 of whom (58%) were treated with multimodal therapy, underwent CCTA, echocardiography, electrocardiography (ECG), and treadmill stress testing. Obstructive CAD was defined as ≥50% occlusion of the left main or ≥70% occlusion of the left anterior descending, left circumflex, or right coronary arteries on CCTA. Echocardiograms with resting wall motion abnormalities or an ejection fraction <50%; ECGs with Q waves, ST abnormalities without Q waves, or T-wave abnormalities without Q waves; and a J-point depression of ≥1 mm with a horizontal or downsloping ST segment on stress testing were considered abnormal. RESULTS: The prevalence of disease in participants (median age, 40 years [range, 26 years-55 years]; median time from cancer diagnosis, 24 years [range, 17 years-39 years]) was 39%, with 39 plaques detected among 12 survivors. Three participants (10%) treated with RT only had 4 obstructive lesions; 9 patients (29%; 5 of whom were treated with RT only and 4 of whom were treated with multimodal therapy) had nonobstructive lesions. Approximately 15% of lesions involved the left main, 21% involved the proximal left anterior descending, 18% involved the proximal right coronary, and 13% involved the proximal left circumflex arteries. Of the 12 participants found to have CAD by CCTA, 7 had a positive ECG, 1 had a positive echocardiogram, and 1 had a positive stress test. CONCLUSIONS:CCTA identified CAD in a substantial percentage of survivors of HL and may be an effective screening modality for this population.
Authors: W G Austen; J E Edwards; R L Frye; G G Gensini; V L Gott; L S Griffith; D C McGoon; M L Murphy; B B Roe Journal: Circulation Date: 1975-04 Impact factor: 29.690
Authors: Berthe M P Aleman; Alexandra W van den Belt-Dusebout; Marie L De Bruin; Mars B van 't Veer; Margreet H A Baaijens; Jan Paul de Boer; Augustinus A M Hart; Willem J Klokman; Marianne A Kuenen; Gabey M Ouwens; Harry Bartelink; Flora E van Leeuwen Journal: Blood Date: 2006-11-21 Impact factor: 22.113
Authors: Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart Journal: J Am Soc Echocardiogr Date: 2005-12 Impact factor: 5.251
Authors: Gregory T Armstrong; Kevin C Oeffinger; Yan Chen; Toana Kawashima; Yutaka Yasui; Wendy Leisenring; Marilyn Stovall; Eric J Chow; Charles A Sklar; Daniel A Mulrooney; Ann C Mertens; William Border; Jean-Bernard Durand; Leslie L Robison; Lillian R Meacham Journal: J Clin Oncol Date: 2013-09-03 Impact factor: 44.544
Authors: Wendy Landier; Smita Bhatia; Debra A Eshelman; Katherine J Forte; Teresa Sweeney; Allison L Hester; Joan Darling; F Daniel Armstrong; Julie Blatt; Louis S Constine; Carolyn R Freeman; Debra L Friedman; Daniel M Green; Neyssa Marina; Anna T Meadows; Joseph P Neglia; Kevin C Oeffinger; Leslie L Robison; Kathleen S Ruccione; Charles A Sklar; Melissa M Hudson Journal: J Clin Oncol Date: 2004-12-02 Impact factor: 44.544
Authors: Joseph R Carver; Charles L Shapiro; Andrea Ng; Linda Jacobs; Cindy Schwartz; Katherine S Virgo; Karen L Hagerty; Mark R Somerfield; David J Vaughn Journal: J Clin Oncol Date: 2007-06-18 Impact factor: 44.544
Authors: Jürgen Rademaker; Heiko Schöder; Nikki S Ariaratnam; Harry W Strauss; Joachim Yahalom; Richard Steingart; Kevin C Oeffinger Journal: AJR Am J Roentgenol Date: 2008-07 Impact factor: 3.959
Authors: Daniel C Bowers; D Elizabeth McNeil; Yan Liu; Yutaka Yasui; Marilyn Stovall; James G Gurney; Melissa M Hudson; Sarah S Donaldson; Roger J Packer; Pauline A Mitby; Catherine E Kasper; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2005-09-20 Impact factor: 50.717
Authors: Kirsten K Ness; Gregory T Armstrong; Mondira Kundu; Carmen L Wilson; Tamara Tchkonia; James L Kirkland Journal: Cancer Date: 2014-12-19 Impact factor: 6.860
Authors: Daniel A Mulrooney; Gregory T Armstrong; Sujuan Huang; Kirsten K Ness; Matthew J Ehrhardt; Vijaya M Joshi; Juan Carlos Plana; Elsayed Z Soliman; Daniel M Green; Deokumar Srivastava; Aimee Santucci; Matthew J Krasin; Leslie L Robison; Melissa M Hudson Journal: Ann Intern Med Date: 2016-01-05 Impact factor: 25.391
Authors: Mirela Tuzovic; Joerg Herrmann; Cezar Iliescu; Kostas Marmagkiolis; Boback Ziaeian; Eric H Yang Journal: Curr Treat Options Cardiovasc Med Date: 2018-04-07
Authors: Elizabeth A M Feijen; Anna Font-Gonzalez; Elvira C van Dalen; Helena J H van der Pal; Raoul C Reulen; David L Winter; Claudia E Kuehni; Riccardo Haupt; Daniela Alessi; Julianne Byrne; Edit Bardi; Zsuzsanna Jakab; Desiree Grabow; Stanislaw Garwicz; Momcilo Jankovic; Gill A Levitt; Roderick Skinner; Lorna Zadravec Zaletel; Lars Hjorth; Wim J E Tissing; Florent de Vathaire; Mike M Hawkins; Leontien C M Kremer Journal: PLoS One Date: 2016-09-19 Impact factor: 3.240
Authors: Michel Zimmermann; Christoph Oehler; Ulrich Mey; Pirus Ghadjar; Daniel Rudolf Zwahlen Journal: Radiat Oncol Date: 2016-08-30 Impact factor: 3.481
Authors: Daniel A Mulrooney; Geehong Hyun; Kirsten K Ness; Matthew J Ehrhardt; Yutaka Yasui; Daniel Duprez; Rebecca M Howell; Wendy M Leisenring; Louis S Constine; Emily Tonorezos; Todd M Gibson; Leslie L Robison; Kevin C Oeffinger; Melissa M Hudson; Gregory T Armstrong Journal: BMJ Date: 2020-01-15